The Future of Ketamine in the Treatment of Teen Depression

Am J Psychiatry. 2021 Apr 1;178(4):288-289. doi: 10.1176/appi.ajp.2020.21020172.

Authors

Tapan Parikh¹, John T Walkup¹

Affiliation

¹ Pritzker Department of Psychiatry and Behavioral Health, Ann and Robert H. Lurie Children's Hospital of Chicago; and Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine.

PMID: 33789452
DOI: 10.1176/appi.ajp.2020.21020172

No abstract available

Keywords: Child/Adolescent Psychiatry; Depressive Disorders; Ketamine/Esketamine; Teen; Treatment.

Publication types

Editorial
Comment

MeSH terms

Adolescent
Antidepressive Agents / therapeutic use
Depression
Depressive Disorder, Treatment-Resistant* / drug therapy
Humans
Ketamine* / therapeutic use
Midazolam / therapeutic use

Substances

Antidepressive Agents
Ketamine
Midazolam